Identification & characterisation of novel antigens in ovarian cancer

• Research type

  Research Study

• Full title

  Analysis of Tumour Associated Antigen Gene and Protein Expression in Ovarian Cancer – Analysis of Cells and Body Fluids

• IRAS ID

  137595

• Sponsor organisation

  University of Hull

• Duration of Study in the UK

  9 years, 11 months, 30 days

• Research summary

  We want to see whether there are differences in the urine and blood of patients with ovarian cancer, compared to people who don't have cancer, which we could use to detect cancer earlier when it's easier to treat. We really want to develop a test that doesn't require tumour to be taken or complicated tests so a urine test would be ideal. We are asking patients to donate some urine when they are diagnosed and while they are being treated to see if there is a marker we can use to detect cancer. Just to make sure we have the best chance of finding ovarian cancer early before patients have symptoms, and when it is easier to treat, we also want to look in patient blood for differences between people with ovarian cancer and those without it.

• REC name

  East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

• REC reference

  18/EE/0271

• Date of REC Opinion

  30 Sep 2018

• REC opinion

  Further Information Favourable Opinion